Summary
- Revenue
- AKRO current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for AKRO has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Akero Therapeutics, Inc. |
| Ticker | NASDAQ: AKRO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | akerotx.com |
| Employees | 74 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| - | N/A | |
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.75 | ||
| EPS, 1Y Change | -30.05% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.75 | ||
| EPS Estimate | -$3.94 | N/A |
| EPS Est. Change | -4.81% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | - | |
| Price Target | $57.00 | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.84 | -$2.89 | -1.65% | |
| -$3.95 | -$3.75 | +4.99% | |
| -$3.94 | N/A | -4.81% | |
| -$4.22 | N/A | -12.45% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | - | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$3.75 | ||
| -$18.00K | ||
| - | ||
| -$285.42M | ||
| - | ||
| -$252.06M | ||
| - | ||
| -$285.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.05 | ||
| 19.38 | ||
| 19.38 | ||
| - | ||
| - | ||
| - |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $750.11M | ||
| $340.24M | ||
| $825.89M | ||
| $770.38M | ||
| $75.77M | ||
| $39.75M | ||
| $36.12M | ||
| $291.00K | ||
| $9.03M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $252.06M | ||
| $285.41M | ||
| $18.00K | ||
| $0.00 | ||
| $18.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$230.11M | ||
| -$109.71M | ||
| $445.85M | ||
| $0.00 | ||
| -$230.11M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wolfe Research | → | |
| HC Wainwright & Co. | → | |
| Jefferies | → | |
| Canaccord Genuity | → | |
| TD Cowen | ||
| B of A Securities | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| UBS | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
No data
Screeners with AKRO
FAQ
- What is the ticker symbol for Akero Therapeutics, Inc.?
- The ticker symbol for Akero Therapeutics, Inc. is NASDAQ:AKRO
- Does Akero Therapeutics, Inc. pay dividends?
- No, Akero Therapeutics, Inc. does not pay dividends
- What sector is Akero Therapeutics, Inc. in?
- Akero Therapeutics, Inc. is in the Healthcare sector
- What industry is Akero Therapeutics, Inc. in?
- Akero Therapeutics, Inc. is in the Biotechnology industry
- What country is Akero Therapeutics, Inc. based in?
- Akero Therapeutics, Inc. is headquartered in United States
- When did Akero Therapeutics, Inc. go public?
- Akero Therapeutics, Inc. initial public offering (IPO) was on June 20, 2019
- Is Akero Therapeutics, Inc. in the S&P 500?
- No, Akero Therapeutics, Inc. is not included in the S&P 500 index
- Is Akero Therapeutics, Inc. in the NASDAQ 100?
- No, Akero Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Akero Therapeutics, Inc. in the Dow Jones?
- No, Akero Therapeutics, Inc. is not included in the Dow Jones index
- When was Akero Therapeutics, Inc. last earnings report?
- Akero Therapeutics, Inc.'s most recent earnings report was on February 27, 2026
- When does Akero Therapeutics, Inc. report earnings?
- The date for Akero Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- AKRO Official Website akerotx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1744659/000119312525272569/0001193125-25-272569-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1744659/000095017025029514/0000950170-25-029514-index.htm
- AKRO Profile on Yahoo Finance finance.yahoo.com/quote/AKRO
- AKRO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/akro